NCT07520513

Brief Summary

This prospective case series aims to evaluate the clinical and radiographic outcomes of immediate implant placement using the socket shield technique combined with concentrated growth factors (CGF) and xenograft in the esthetic zone. The study will assess crestal bone level changes and implant stability over a 6-month follow-up period.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
7

participants targeted

Target at below P25 for not_applicable

Timeline
7mo left

Started Apr 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress27%
Apr 2026Dec 2026

First Submitted

Initial submission to the registry

April 3, 2026

Completed
2 days until next milestone

Study Start

First participant enrolled

April 5, 2026

Completed
4 days until next milestone

First Posted

Study publicly available on registry

April 9, 2026

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2026

Expected
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2026

Last Updated

April 13, 2026

Status Verified

April 1, 2026

Enrollment Period

5 months

First QC Date

April 3, 2026

Last Update Submit

April 8, 2026

Conditions

Keywords

immediate implantssocket shield techniqueConcentrated growth factorXenograft

Outcome Measures

Primary Outcomes (1)

  • crestal bone level

    Evaluation of changes in crestal bone level around the dental implant using cone-beam computed tomography (CBCT). Measurements will be taken from a fixed reference point on the implant to the first bone-to-implant contact recorded in millimeters (mm)

    2 weeks, and 6 months postoperatively

Secondary Outcomes (1)

  • Implant Stability (ISQ Values)

    Immediate postoperative, and at 6 months

Study Arms (1)

Socket Shield Technique with CGF and Xenograft in Immediate Implant Placement

EXPERIMENTAL

Participants will undergo immediate implant placement in the esthetic zone using the socket shield technique. Following partial extraction therapy, implants will be placed immediately, and the jumping gap will be filled using a combination of concentrated growth factors (CGF) and xenograft prepared as "sticky bone." Clinical and radiographic follow-up will be conducted over a 6-month period to evaluate crestal bone levels and implant stability.

Procedure: Socket Shield Technique with Immediate Implant Placement and CGF + Xenograft

Interventions

The procedure involves partial extraction therapy using the socket shield technique, where the buccal portion of the root is preserved to maintain the alveolar bone. Immediate implant placement is performed into the extraction socket. Concentrated growth factors (CGF) are prepared from the patient's autologous blood via centrifugation and combined with xenograft to form a "sticky bone" graft. This graft is placed in the jumping gap between the implant and socket wall to enhance bone regeneration and healing. Implant stability will be measured using resonance frequency analysis (Osstell), and radiographic evaluation will be performed using CBCT.

Socket Shield Technique with CGF and Xenograft in Immediate Implant Placement

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age ≥18 years old. (Younis, W., \& El-Rashidy, A. 2020).
  • Both male and female patients.
  • Maxillary, anterior and premolar segments.

You may not qualify if:

  • A medical history that contraindicates oral surgical treatment such as (uncontrolled/untreated diabetes mellitus, immuno-compromised status, radio or chemotherapy of the oral and maxillofacial region, treatment with oral and/or intravenous bisphosphonates).
  • Presence of active or untreated periodontal disease.
  • Vertical root fractures involving the buccal aspect.
  • Tooth /teeth with horizontal fractures below bone level.
  • Tooth /teeth with external or internal resorption.
  • Patients with destructive oral habits such as smoking, chewing tobacco, bruxism, etcetera.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of Dentistry, Cairo University

Cairo, Cairo Governorate, 11553, Egypt

Location

MeSH Terms

Conditions

Alveolar Bone LossBone Resorption

Interventions

Immediate Dental Implant LoadingTransplantation, Heterologous

Condition Hierarchy (Ancestors)

Bone DiseasesMusculoskeletal DiseasesPeriodontal AtrophyPeriodontal DiseasesMouth DiseasesStomatognathic Diseases

Intervention Hierarchy (Ancestors)

Dental Implantation, EndosseousDental ImplantationOral Surgical Procedures, PreprostheticOral Surgical ProceduresSurgical Procedures, OperativeProsthesis ImplantationDentistryProsthodonticsTransplantation

Study Officials

  • Tarek I.A El-Ghareeb, PHD Holder

    Cairo University

    STUDY CHAIR
  • Abdelmoez Mohamed EL-Sharkawy, Associate professor

    Cairo University

    STUDY DIRECTOR

Central Study Contacts

Huda Ayman Alrifai, bachelors

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

April 3, 2026

First Posted

April 9, 2026

Study Start

April 5, 2026

Primary Completion (Estimated)

September 1, 2026

Study Completion (Estimated)

December 30, 2026

Last Updated

April 13, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share

Locations